| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | Welltower Inc | 8,378 | 529,000 | 0.09% | ||
| 102 | CLOVIS ONCOLOGY INC | 7,797 | 496,000 | 0.09% | ||
| 103 | IMMUNOMEDICS INCORPORATED | 75,034 | 485,000 | 0.09% | ||
| 104 | LA JOLLA PHARMACEUTICAL CO | 15,848 | 473,000 | 0.08% | ||
| 105 | SHELL MIDSTREAM PARTNERS L P | 14,348 | 462,000 | 0.08% | ||
| 106 | KITE PHARMA INCORPORATED | 5,877 | 461,000 | 0.08% | ||
| 107 | PINNACLE WEST | 5,508 | 459,000 | 0.08% | ||
| 108 | XCEL ENERGY INC | 10,178 | 452,000 | 0.08% | ||
| 109 | LOXO ONCOLOGY INC COM | 10,408 | 438,000 | 0.08% | ||
| 110 | EPIZYME INC COM | 25,328 | 434,000 | 0.08% | ||
| 111 | BIOCRYST PHARMACEUTICALS | 50,888 | 427,000 | 0.08% | ||
| 112 | BLUEPRINT MEDICINES CORP COM | 10,690 | 427,000 | 0.08% | ||
| 113 | AVEXIS INC COM | 5,585 | 425,000 | 0.08% | ||
| 114 | SAGE THERAPEUTICS INC | 5,837 | 415,000 | 0.07% | ||
| 115 | KARYOPHARM THERAPEUTICS INC COM | 30,356 | 390,000 | 0.07% | ||
| 116 | FIDELITY | 10,900 | 389,000 | 0.07% | ||
| 117 | PARATEK PHARMACEUTICALS INC | 20,209 | 389,000 | 0.07% | ||
| 118 | INSMED INC | 21,882 | 383,000 | 0.07% | ||
| 119 | RIGEL PHARMACEUTICAL INC | 112,403 | 372,000 | 0.07% | ||
| 120 | BLUEBIRD BIO INC COM | 4,056 | 369,000 | 0.07% | ||
| 121 | VANGUARD INDEX FDS | 4,415 | 365,000 | 0.07% | ||
| 122 | BEIGENE LTD | 9,669 | 354,000 | 0.06% | ||
| 123 | SERES THERAPEUTICS INC | 31,133 | 351,000 | 0.06% | ||
| 124 | JUNO THERAPEUTICS INC COM | 15,654 | 347,000 | 0.06% | ||
| 125 | AMICUS THERAPEUTICS INC COM | 47,843 | 341,000 | 0.06% | ||
| 126 | FIBROGEN INC | 13,754 | 339,000 | 0.06% | ||
| 127 | Axovant Sciences LTD | 22,301 | 333,000 | 0.06% | ||
| 128 | ONCOMED PHARMACEUTICALS INC COM | 36,113 | 333,000 | 0.06% | ||
| 129 | ALNYLAM PHARMACEUTICALS INC | 6,478 | 332,000 | 0.06% | ||
| 130 | CYTOKINETICS INC | 24,879 | 320,000 | 0.06% | ||
| 131 | GERON CORP | 137,195 | 311,000 | 0.06% | ||
| 132 | AGIOS PHARMACEUTICALS INC | 5,269 | 308,000 | 0.05% | ||
| 133 | PUMA BIOTECHNOLOGY | 8,147 | 303,000 | 0.05% | ||
| 134 | AQUINOX PHARMACEUTICALS INC | 18,080 | 302,000 | 0.05% | ||
| 135 | INTRA-CELLULAR THERAPIES INC | 18,329 | 298,000 | 0.05% | ||
| 136 | FELCOR LODGING TR INC PFD CV A $1.95 | 12,128 | 296,000 | 0.05% | ||
| 137 | PROTHENA CORP PLC | 5,303 | 296,000 | 0.05% | ||
| 138 | LION BIOTECHNOLOGIES INC COM | 39,420 | 294,000 | 0.05% | ||
| 139 | ACHILLION PHARMACEUTICALS IN | 69,450 | 292,000 | 0.05% | ||
| 140 | REATA PHARMACEUTICALS INC | 12,909 | 292,000 | 0.05% | ||
| 141 | ARRAY BIOPHARMA INC | 32,023 | 286,000 | 0.05% | ||
| 142 | SPARK THERAPEUTICS INCORPORATED | 5,361 | 286,000 | 0.05% | ||
| 143 | SYNERGY PHARMACEUTICALS DEL | 61,108 | 285,000 | 0.05% | ||
| 144 | ZIOPHARM ONCOLOGY INC | 44,638 | 283,000 | 0.05% | ||
| 145 | NEUROCRINE BIOSCIE COM USD0.001 | 6,475 | 280,000 | 0.05% | ||
| 146 | NOVAVAX INC COM | 216,960 | 278,000 | 0.05% | ||
| 147 | MYOKARDIA INC | 20,886 | 275,000 | 0.05% | ||
| 148 | ADURO BIOTECH INC | 25,559 | 275,000 | 0.05% | ||
| 149 | CELLDEX THERAPEUTICS INC NEW | 75,237 | 272,000 | 0.05% | ||
| 150 | AIMMUNE THERAPEUTICS INC COM | 12,472 | 271,000 | 0.05% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-17-005056, filed 2017.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
